Epitech Group S.p.a.

Vito Safina

Maria Federica Della Valle

Gabriele Marcolongo

Salvatore Cuzzocrea

Chiara Gomiero

Annalisa Noce

Giuseppe Esposito

Giuliano Claps

The present invention relates to a method of treating a COVID-19 infection by administering an effective amount of an endogenous compound devoid of significant toxicity. In particular, the present invention relates to a method of treating a patient affected by COVID-19 infection comprising administering an effective amount of a mixture of ultra-micronized palmitoylethanolamide and micronized palmitoylethanolamide to said patient.

Method for the treatment of COVID-19 infections with palmitoylethanolamide

Described herein is a composition based on N-palmitoyl-ethanolamide and Rutin in co-micronized form. In particular, a composition includes a mixture of palmitoyl-ethanolamide (PEA) and Rutin in co-micronized form in which the PEA/Rutin ratio is between 10:1 and 1:1. Pharmaceutical formulations for the treatment of humans and animals are also described. The composition is useable for the treatment of diseases of arteries and arterioles.

Composition of N-palmitoyl-ethanolamide and Rutin in co-micronized form

Growing community of inventors

Milan, Italy

Vito Safina